McGillen K, Pryor 3rd W, Yee N, Zhu J, Krok K, Waybill P
J Clin Med. 2025; 13(24.
PMID: 39768642
PMC: 11676969.
DOI: 10.3390/jcm13247720.
Crosby J, Bassetti M, Hurst Jr N, Kruser T, Glide-Hurst C
Cureus. 2024; 15(12):e50459.
PMID: 38222202
PMC: 10784766.
DOI: 10.7759/cureus.50459.
Chartampilas E, Rafailidis V, Georgopoulou V, Kalarakis G, Hatzidakis A, Prassopoulos P
Cancers (Basel). 2022; 14(16).
PMID: 36010991
PMC: 9406360.
DOI: 10.3390/cancers14163997.
Chang W, Hsu H, Chiu S, Huang W, Lo C, Lin H
J Hepatocell Carcinoma. 2021; 8:937-949.
PMID: 34422707
PMC: 8373306.
DOI: 10.2147/JHC.S319920.
Daldrup-Link H, Theruvath A, Rashidi A, Iv M, Majzner R, Spunt S
Pediatr Radiol. 2021; 52(2):354-366.
PMID: 34046709
PMC: 8626538.
DOI: 10.1007/s00247-021-05098-5.
Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Byun H, Kim N, Seong J
Yonsei Med J. 2021; 62(5):409-416.
PMID: 33908211
PMC: 8084693.
DOI: 10.3349/ymj.2021.62.5.409.
Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.
Aslam A, Kamath A, Spieler B, Maschiocchi M, Sabottke C, Chernyak V
Abdom Radiol (NY). 2021; 46(8):3565-3578.
PMID: 33856509
DOI: 10.1007/s00261-021-03076-x.
MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review.
Mendiratta-Lala M, Masch W, Shampain K, Zhang A, Jo A, Moorman S
Radiol Imaging Cancer. 2021; 2(1):e190024.
PMID: 33778692
PMC: 7983779.
DOI: 10.1148/rycan.2020190024.
Interreader Reliability of Liver Imaging Reporting and Data System Treatment Response: A Systematic Review and Meta-Analysis.
Kim D, Choi S, Lee J, Kim S, Lee S, Byun J
Diagnostics (Basel). 2021; 11(2).
PMID: 33557040
PMC: 7913820.
DOI: 10.3390/diagnostics11020237.
Imaging of ocular melanoma metastasis.
Balasubramanya R, Selvarajan S, Cox M, Joshi G, Deshmukh S, Mitchell D
Br J Radiol. 2016; 89(1065):20160092.
PMID: 27168029
PMC: 5124918.
DOI: 10.1259/bjr.20160092.
DYNA CT arteriographic evaluation of hepatocellular carcinoma for treatment by trans-catheter arterial chemoembolization.
Wang C, Wang Q, Chen W, He Z, Huang Y, Lu Y
Int J Clin Exp Med. 2016; 8(11):20548-55.
PMID: 26884972
PMC: 4723817.
Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M, Golovko D, Ansari C, Marina N, Pisani L, Kurlander L
PLoS One. 2015; 10(11):e0142665.
PMID: 26569397
PMC: 4646285.
DOI: 10.1371/journal.pone.0142665.
Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.
Willatt J, Hannawa K, Ruma J, Frankel T, Owen D, Barman P
World J Hepatol. 2015; 7(2):235-44.
PMID: 25729478
PMC: 4342605.
DOI: 10.4254/wjh.v7.i2.235.
Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization.
Yuan Z, Li W, Ye X, Peng W, Xiao X
Oncol Lett. 2014; 8(2):831-836.
PMID: 25013505
PMC: 4081130.
DOI: 10.3892/ol.2014.2228.
Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.
Kohles N, Nagel D, Jungst D, Stieber P, Holdenrieder S
Tumour Biol. 2012; 33(6):2401-9.
PMID: 22965881
DOI: 10.1007/s13277-012-0504-2.
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.
Kohles N, Nagel D, Jungst D, Durner J, Stieber P, Holdenrieder S
Tumour Biol. 2011; 33(1):33-40.
PMID: 21931992
DOI: 10.1007/s13277-011-0237-7.
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients.
Kohles N, Nagel D, Jungst D, Durner J, Stieber P, Holdenrieder S
BMC Cancer. 2011; 11:202.
PMID: 21615953
PMC: 3118895.
DOI: 10.1186/1471-2407-11-202.
Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.
Ippolito D, Bonaffini P, Ratti L, Antolini L, Corso R, Fazio F
World J Gastroenterol. 2010; 16(47):5993-6000.
PMID: 21157976
PMC: 3007114.
DOI: 10.3748/wjg.v16.i47.5993.
Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation.
Van Vledder M, Boctor E, Assumpcao L, Rivaz H, Foroughi P, Hager G
HPB (Oxford). 2010; 12(10):717-23.
PMID: 21083798
PMC: 3003483.
DOI: 10.1111/j.1477-2574.2010.00247.x.
Current role of ultrasound for the management of hepatocellular carcinoma.
Maruyama H, Yoshikawa M, Yokosuka O
World J Gastroenterol. 2008; 14(11):1710-9.
PMID: 18350602
PMC: 2695911.
DOI: 10.3748/wjg.14.1710.
